Anticancer Activity of Extracellular Vesicles Derived From Adipose Mesenchymal Stem Cells of Macaca fascicularis on WiDr Colon Cancer Cells.
Al-Ozeir FW., Mayasari NLPI., Mariya S., Indriawati I., Dayana H., Darusman HS.
Animal Study, published in J Med Primatol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- J Med Primatol (2026)
- Country
- Denmark
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42144563
- DOI
- 10.1111/jmp.70080
Abstract (original English)
Colon cancer death toll due to metastasis is expected to rise. Extracellular vesicles are signalling molecules which can regulate communication between cells and either inhibit or promote cancer metastasis. Extracellular vesicles from adipose mesenchymal stem cells of Macaca fascicularis were obtained from previous research. Various concentrations of extracellular vesicles (5 μg/mL, 10 μg/mL, and 20 μg/mL) were applied to colon cancer cell line WiDr in a transwell invasion assay. CXCR3 gene expression analysis was done using RT-qPCR. Application of extracellular vesicles successfully inhibited colon cancer invasion with decrease of number of invasive cells with increase in concentration. There was no statistical difference between cells treated with 10 μg/mL and 20 μg/mL of extracellular vesicles. Colon cancer cells treated with extracellular vesicles show upregulation of CXCR3A and CXCR3B gene expression compared to negative control. Extracellular vesicles inhibit colon cancer cell invasion through upregulation of CXCR3B expression.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.